middle.news
Lumos Secures US$767,800 FebriDx Order After FDA CLIA Waiver Boost
9:04am on Tuesday 4th of August, 2026 AEST
•
Healthcare
Read Story
Lumos Secures US$767,800 FebriDx Order After FDA CLIA Waiver Boost
9:04am on Tuesday 4th of August, 2026 AEST
Key Points
US$767,800 FebriDx order from PHASE Scientific
Order linked to US$5 million FDA CLIA waiver prepayment
Delivery scheduled through October 2026
Order fulfills Year 1 minimum purchase commitment
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Lumos Diagnostics (ASX:LDX)
OPEN ARTICLE